Placebo News and Research

RSS

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

New anti-smoking drug Varenicline (Chantix) promotes longer-lasting abstinence

Scientists have found that a new anti-smoking drug may be more effective than drugs currently in use to help smokers kick the habit and it has the added advantage of promoting longer-lasting abstinence.

5 Jul 2006

Some common inhalers double death rate in chronic obstructive pulmonary disease patients

Some common inhalers double death rate in chronic obstructive pulmonary disease patients

A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory deaths, but the other - which is prescribed in the majority of cases - increases respiratory deaths.

4 Jul 2006

Varenicline effective in helping smokers quit

Varenicline effective in helping smokers quit

The drug varenicline shows effectiveness in helping smokers quit and abstain from smoking when compared to placebo and the smoking cessation medication bupropion.

4 Jul 2006

Popular antihistamine used to help young children sleep is ineffective

Popular antihistamine used to help young children sleep is ineffective

Although about half of pediatricians recommend that children under age 2 can be given diphenhydramine to help them sleep, the first study to look at effectiveness of the agent in children who are that young found no benefit.

4 Jul 2006

Gabapentin is as effective as estrogen for menopause symptoms

Gabapentin is as effective as estrogen for menopause symptoms

University of Rochester researchers, who have been investigating new therapies for hot flashes for several years, report in the July Obstetrics and Gynecology journal that the seizure drug gabapentin is as effective as estrogen

3 Jul 2006

Benadryl does not improve infant sleep

Benadryl does not improve infant sleep

An antihistamine often recommended to parents whose infants do not sleep through the night may not be effective in reducing nighttime awakenings or improving parents' happiness with their children's sleep.

3 Jul 2006

FDA approves Exelon to treat dementia of Parkinson's disease

FDA approves Exelon to treat dementia of Parkinson's disease

FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.

27 Jun 2006

Study on the effects of alcohol and risk produces surprising results

Study on the effects of alcohol and risk produces surprising results

In a report published by the Journal of Studies on Alcohol, researchers have stated that whereas individuals find risky choices significantly more attractive after consuming a moderate amount of alcohol, groups do not.

26 Jun 2006

Experimental drug helps you age gracefully

Experimental drug helps you age gracefully

Researchers in the U.S. say they believe an experimental drug designed to kick-start growth hormones in humans may also be of advantage in the aging process.

22 Jun 2006

Omega-3 fatty acids benefit children with depression

Omega-3 fatty acids benefit children with depression

Major depressive disorders in children are possibly more common than once thought, and the benefits of additional supplements are unclear.

22 Jun 2006

Zap that migraine before it even starts!

Zap that migraine before it even starts!

Millions of people who suffer from migraine could be helped by an experimental device which zaps the pain before an attack gets going.

22 Jun 2006

'Love hormone' oxytocin may help battle stress

'Love hormone' oxytocin may help battle stress

According to new research a hormone that relaxes women during childbirth and breastfeeding has other uses.

21 Jun 2006

Chlorhexidine decreases risk of acquiring hospital-related ventilator-associated pneumonia

Chlorhexidine decreases risk of acquiring hospital-related ventilator-associated pneumonia

Researchers found that administering the topical antiseptic chlorhexidine to critically ill patients on mechanical ventilation greatly decreased their daily risk of acquiring deadly hospital-related ventilator-associated pneumonia.

18 Jun 2006

Safe for cystic fibrosis patients to stop using inhaled corticosteroids

Safe for cystic fibrosis patients to stop using inhaled corticosteroids

In comparison to cystic fibrosis (CF) patients who regularly use inhaled corticosteroid, those who did not use these drugs for six months exhibited no positive or negative effects in terms of major disease factors.

18 Jun 2006

Pycnogenol significantly reduces muscular pain

Pycnogenol significantly reduces muscular pain

A study published in this month's issue of Angiology shows that supplementation with the pine bark extract Pycnogenol. (pic-noj-en-all) improves blood flow to the muscles which speeds recovery after physical exercise.

18 Jun 2006

Anorexia not alleviated by anti-depressants

Anorexia not alleviated by anti-depressants

Patients battling to deal with the eating disorder anorexia nervosa, do not benefit or prevent relapses of the life-threatening eating disorder by taking the anti-depressant Prozac.

14 Jun 2006

New drug will treat those winter blues

New drug will treat those winter blues

The U.S. Food and Drug Administration (FDA) has given it's approval for a drug to treat a condition known as Seasonal Affective Disorder (SAD).

14 Jun 2006

FDA approves Wellbutrin X for treatment of seasonal depression

FDA approves Wellbutrin X for treatment of seasonal depression

The Food and Drug Administration (FDA) has approved Wellbutrin XL for prevention of major depressive episodes in patients with a history of seasonal affective disorder (SAD).

13 Jun 2006

The n-of-1 trial: An opportunity for complementary and alternative medicine evaluation

The n-of-1 trial: An opportunity for complementary and alternative medicine evaluation

It is an extremely interesting rationale for the use of n-of-1 randomized trials, particularly for complementary and alternative medicine evaluation in the treatment of chronic, difficult to treat disorders.

13 Jun 2006

Predictive model of prostate cancer risk

Predictive model of prostate cancer risk

Combining PSA with other risk factors for prostate cancer (CaP) may result in individualized risk prediction.

13 Jun 2006

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.